业内资讯

成功故事:复星医药

更新日期:2015-12-01 阅读量:2233 所属类别:业内资讯

Success Story:Shanghai Fosun Pharma


在第三季度,SAP大中华区销售团队成功地签单复星医药。作为中国医疗行业的领先企业,复星医药正处于数字化转型阶段。复星医药希望通过实施 S/4HANASoHCRM

hybrisMDMMII,实现全球创新,树立行业新标杆,以期成为中国最具价值的医疗保健企业。SAP将帮助复星医药推动内部管理和控制流程的标准化和简易化,整合平台支持,使其与行业管理规范接轨。


在签单的过程中,SAP团队遇到了哪些困难呢?他们又是怎样克服的呢?赢得复星医药对于SAP具有怎样的意义?


微信截图_20151201173429.png

视频采访: 邓永富 SAP中国副总裁 消费品及生命科学行业


视频链接地址:https://jam4.sapjam.com/saml/saml2_sso?company_id=sf&idp=accounts-jamatsap.sap.com


本文摘自:Employee Communications, SAP Greater China


In Q3 2015, SAP Greater China successfully signed a contract with Shanghai Fosun Pharma, a leading health care company in China. Fosun Pharma is embarking on a digital transformation by implementing S/4HANA, Suite on HANA, CRM, hybris, MDM, and MII to help achievetheir goals of global innovation, setting the industry standard ahead of the  competition, and becoming China’s most valuable medical and health care business. SAP will standardize and simplify Fosun Pharma’s internal management  and controlling processes, integrate platform support, and bring the company  into compliance with industry management rules.    


What are the obstacles to gaining this new customer, and what is the secret that takes the team over the obstacles?What makes this new win special for SAP?


Video interview:  Andy Deng, Vice President, SAP China, Consumer Products & Life Science



本文摘自:Employee Communications, SAP Greater China